Key Highlights
- Shares declined approximately 5.4% Monday, reaching a fresh 52-week low of $14.62
- CEO Sean Connolly to depart May 31 after a decade in leadership; John Brase assumes role June 1
- Third-quarter earnings per share of $0.39 fell short of the $0.40 Wall Street estimate
- Wall Street analysts reduced price targets across the board; average target now stands at $16.07 with a “Reduce” consensus
- Annual dividend yield reaches ~9.8% while deeply negative payout ratio sparks viability concerns
Conagra Brands experienced another difficult session Monday as shares fell approximately 5.4%, marking a new 52-week low of $14.62. Trading activity surged, with close to 2 million shares exchanging hands throughout the session.
The decline followed a major leadership announcement. Sean Connolly, who has led the company as chief executive for a decade, will depart on May 31. The board selected John Brase to succeed him, with his tenure beginning June 1.
Brase brings extensive industry experience to the position. His background includes serving as chief operating officer at J.M. Smucker and holding multiple senior positions at Procter & Gamble. Conagra confirmed he will simultaneously join the company’s board.
Wall Street Response Reflects Concern
BofA Securities maintained its Underperform stance while holding its $15 price target on CAG shares. The investment bank characterized the announcement timing as unexpected and identified multiple challenges awaiting the new chief executive.
Primary among those obstacles: inflation dynamics that pressured earnings in fiscal 2026 and threaten to constrain fiscal 2027 performance. BofA highlighted the dividend payout ratio, currently exceeding 80% — significantly above the company’s stated 50–55% target range.
The company’s net debt to EBITDA ratio stands at 3.8x. BofA raised the possibility of strategic divestitures to improve the balance sheet, specifically mentioning Hebrew National and Odom’s Tennessee Pride as brands previously considered for potential sale.
Deutsche Bank reduced its price target to $14 while maintaining a Hold recommendation. JPMorgan and Stifel each lowered their targets to $17. UBS dropped its target from $20 to $16, pointing to margin headwinds and uncertainty around fiscal 2027 performance.
Wall Street’s consensus recommendation currently registers as “Reduce” — comprised of 1 Buy, 12 Hold, and 4 Sell ratings — with a mean price target of $16.07.
Quarterly Results Disappointed Expectations
The company released third-quarter financials on April 1. Earnings per share of $0.39 missed the Street’s $0.40 forecast by a penny. Revenue totaled $2.79 billion, surpassing the $2.76 billion estimate, though quarterly sales declined 1.9% versus the prior-year period.
The comparable quarter last year delivered $0.51 in earnings per share — representing a meaningful decline. Current net margin registers at negative 0.39%, with the price-to-earnings ratio at -142.54.
Organic sales advanced 2.4% during the quarter, supported by a 0.5% uptick in volume and a 1.9% benefit from pricing and product mix. Margin performance, however, came in below forecasts, while a reduced equity contribution from Ardent Mills pressured profitability.
Management tightened its fiscal 2026 outlook following the quarterly report. The Street currently projects full-year earnings per share of $2.35.
CAG currently trades below both its 50-day moving average of $17.52 and 200-day moving average of $17.60. Shares have declined roughly 37% over the trailing twelve months and approximately 10.6% since the start of the calendar year.
The company’s quarterly dividend of $0.35 per share will be paid June 3 to shareholders of record as of April 30. Based on current trading levels, the annualized yield approximates 9.8%.
